Health Trials

Appendiceal Mucinous Neoplasm

2

Review clinical trials related to Appendiceal Mucinous Neoplasm. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms

This is a pilot, open-label clinical trial determining the feasibility of metformin therapy in subjects with pseudomyxoma peritonei (PMP) secondary to appendiceal mucinous neoplasms (AMNs).

Participants needed: 15
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: University of California, IrvineUpdated: Jul 13, 2026Locations: 1
Eligibility criteria

Patients with clinical diagnosis of pseudomyxoma peritonei (PMP) secondary to pr... [+2]

Patients with a clinical diagnosis of PMP secondary to presumed AMNs with resect... [+2]

Read more
Status: Recruiting

Genetics of Appendix Cancer Study

The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.

Participants needed: 700
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Andreana Holowatyj, PhD, MSCIUpdated: Apr 18, 2025Locations: 1
Eligibility criteria

Known diagnosis of appendix cancer in the United States [+7]

Women pregnant at the time of consent [+3]

Read more